20
Apr 2021
Warning that medicine supply into Northern Ireland post-Brexit ‘high risk area’
The chief pharmaceutical officer, Cathy Harrison, has warned that without mitigation, the supply of medical devices and medicines into Northern Ireland would be considered a ‘very high risk area’ post-Brexit. The pharmaceutical industry has a one-year period of grace to make preparations. Until this year, there has been no separate supply chain for Northern Ireland…